Hound Partners’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-175,000
Closed -$1.87M 257
2020
Q4
$1.87M Buy
+175,000
New +$1.87M 0.12% 83